Clinical Trial

The Beijing Childhood Eye Study

Study acronym: BCES
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated April 17, 2025 (before its estimated August 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Axial myopia has emerged as the leading cause of irreversible vision loss in East Asia, driven by its progression to sight-threatening complications including myopic macular degeneration, retinal detachment, open-angle glaucoma, and other complications. In the current study, we aim to observe the natural course of the development , progression, and its associated factors in children
Trial Details
NCT Number NCT06931444
Lead Sponsor Beijing Tongren Hospital
Conditions Myopia
Enrollment 3,760 participants
Start Date 2020-01-01
Primary Completion 2025-08-01 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-17